-
Profit for Good at Rottendorf Pharmaceuticals
Let’s deal with the name first. If you’re like me, it would’ve been a distraction throughout the article if we hadn’t. The company is named after its German founder and patron, Andreas J. Rottendorf (1897-1971). As per the organization’s founding charter, it can’t be changed.
- Categories
- Health Care
- Region
- Europe & Eurasia
- Tags
- vaccines
-
A Working Malaria Vaccine that Can’t Get Money
Tucked away in a few rooms within the Alexandria Life Science and Translational Research Center in Rockville, Maryland, is a 48-member biotechnology company pursuing a singular obsession to eradicate one of the greatest global health challenges in history, malaria. “We’re swinging for the knockout,” says Dr. Stephen Hoffman, who founded Sanaria in 2003. “This is not to take anything away from the incredibly successful work others are doing to distribute bed nets, create educational programs to increase malaria literacy or discover better methods to deliver existing antimalarials. Those efforts are vitally important. But we’re searching for the one blow that will finally end humanity’s fight against this ancient disease: a vaccine.”
- Categories
- Health Care
- Tags
- vaccines
-
Study: Ebola Vaccine May Fall Short
One of the Ebola vaccines about to enter testing in Liberia may not be as potent as researchers had hoped, according to a new study, raising questions about how well it will prevent infection.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Stanford Launches Major Effort to Expedite Vaccine Discovery with $50 Million Grant
The funding will establish the Stanford Human Systems Immunology Center, and will accelerate efforts to develop vaccines for the world's most deadly infectious diseases.
- Categories
- Education, Health Care
-
Bill Gates Dismisses Criticism of High Prices for Vaccines
Criticising the cost of vaccines could lead to pharmaceutical companies withdrawing research funding, warns Gates, as donors pledge $7.5bn for immunisations of children in poor countries.
- Categories
- Health Care
- Tags
- vaccines
-
China Makes First Aid Commitment to Gavi
Despite Gavi, the Vaccine Alliance’s ambitious $7.5 billion target, donors rose up to the challenge and pledged slightly more than the set goal: $7.539 billion. These commitments are a reflection of donors’ continued confidence not only in the alliance’s capability to deliver results but also to provide evidence of value for money.
- Categories
- Health Care
- Region
- South Asia
- Tags
- philanthropy, vaccines
-
Top-Selling Vaccine Made Cheap Shows Challenge to Merck
Asia’s biggest vaccine maker is working on a string of new low-priced offerings that threaten to undercut brands from the world’s biggest pharmaceutical companies.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Gates Sees ‘Miracle’ Tools for AIDS by 2030 in Vaccine and Drugs
Two new tools to fight AIDS should be available by 2030 in the form of a vaccine and new intense drug treatments, ending most cases of a disease that has killed millions in the past 30 years, Bill Gates said.
- Categories
- Health Care
- Tags
- vaccines
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.